Eton Pharmaceuticals Inc
ETON14.420USD
+0.290+2.05%
交易中 （美東）報價延遲15分鐘
386.71M總市值
虧損本益比TTM
關於 Eton Pharmaceuticals Inc 公司
Eton Pharmaceuticals, Inc. 是一家專注於開發和商業化罕見病治療的製藥公司。該公司有六種商業罕見病產品：INCRELEX、ALKINDI SPRINKLE、PKU GOLIKE、卡穀氨酸、無水甜菜鹼和尼替西農。INCRELEX 是一種生物製品，用於治療 2 歲及以上患有嚴重原發性胰島素樣生長因子 1 缺乏症 (SPIGFD) 的兒科患者。ALKINDI SPRINKLE 用於治療兒童腎上腺皮質功能不全。卡穀氨酸用於治療因 N-乙酰穀氨酸合酶 (NAGS) 缺乏引起的高氨血癥。無水甜菜鹼用於治療同型胱氨酸尿症。尼替西農用於治療 1 型遺傳性酪氨酸血癥 (HT-1)。PKU GOLIKE 是一種針對苯丙酮尿症 (PKU) 患者的醫療配方。其產品 Galzin 已獲得 FDA 批准用於治療極爲罕見的威爾遜氏病代謝疾病。
公司簡介
公司代碼ETON
公司名稱Eton Pharmaceuticals Inc
上市日期Nov 09, 2018
CEOMr. Sean E. Brynjelsen
員工數量31
證券類型Ordinary Share
年結日Nov 09
公司地址21925 W Field Pkwy Ste 235
城市DEER PARK
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編60010-7278
電話18477877361
網址https://etonpharma.com/
公司代碼ETON
上市日期Nov 09, 2018
CEOMr. Sean E. Brynjelsen
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Sean E. Brynjelsen
Mr. Sean E. Brynjelsen
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
864.94K
-19.54%
Mr. Charles J. (Chuck) Casamento
Mr. Charles J. (Chuck) Casamento
Independent Director
Independent Director
93.42K
--
Mr. Paul V. Maier
Mr. Paul V. Maier
Independent Director
Independent Director
84.75K
--
Dr. Norbert G. Riedel, Ph.D.
Dr. Norbert G. Riedel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
84.75K
-54.72%
Mr. James R. Gruber
Mr. James R. Gruber
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
21.71K
-34.20%
Ms. Ipek Erdogan Trinkaus
Ms. Ipek Erdogan Trinkaus
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. David C. Krempa
Mr. David C. Krempa
Chief Business Officer
Chief Business Officer
--
--
Ms. Jennifer (Jenn) Adams
Ms. Jennifer (Jenn) Adams
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Sean E. Brynjelsen
Mr. Sean E. Brynjelsen
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
864.94K
-19.54%
Mr. Charles J. (Chuck) Casamento
Mr. Charles J. (Chuck) Casamento
Independent Director
Independent Director
93.42K
--
Mr. Paul V. Maier
Mr. Paul V. Maier
Independent Director
Independent Director
84.75K
--
Dr. Norbert G. Riedel, Ph.D.
Dr. Norbert G. Riedel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
84.75K
-54.72%
Mr. James R. Gruber
Mr. James R. Gruber
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
21.71K
-34.20%
Ms. Ipek Erdogan Trinkaus
Ms. Ipek Erdogan Trinkaus
Chief Commercial Officer
Chief Commercial Officer
--
--
收入明細
FY2025Q1
FY2024
暫無數據
地區USD
名稱
營收
佔比
United States
17.28M
0.00%
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Opaleye Management Inc.
10.66%
EcoR1 Capital, LLC
7.23%
Nantahala Capital Management, LLC
4.38%
The Vanguard Group, Inc.
4.11%
Brynjelsen (Sean E)
3.23%
Other
70.39%
持股股東
持股股東
佔比
Opaleye Management Inc.
10.66%
EcoR1 Capital, LLC
7.23%
Nantahala Capital Management, LLC
4.38%
The Vanguard Group, Inc.
4.11%
Brynjelsen (Sean E)
3.23%
Other
70.39%
股東類型
持股股東
佔比
Hedge Fund
23.40%
Investment Advisor/Hedge Fund
14.24%
Investment Advisor
13.00%
Individual Investor
4.30%
Research Firm
2.40%
Pension Fund
0.39%
Venture Capital
0.04%
Other
42.22%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
157
15.50M
57.78%
-1.82M
2025Q1
154
15.73M
58.88%
-1.49M
2024Q4
125
14.61M
54.85%
+562.47K
2024Q3
98
10.99M
42.37%
-1.69M
2024Q2
94
9.67M
37.40%
-2.32M
2024Q1
94
10.57M
41.25%
-1.37M
2023Q4
96
10.49M
40.94%
-1.03M
2023Q3
99
10.24M
39.99%
-325.57K
2023Q2
102
9.33M
36.53%
-1.39M
2023Q1
130
9.22M
36.30%
-1.78M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Opaleye Management Inc.
2.86M
10.66%
+7.93K
+0.28%
Jun 10, 2025
EcoR1 Capital, LLC
1.94M
7.23%
+109.69K
+6.00%
Mar 31, 2025
Nantahala Capital Management, LLC
1.18M
4.38%
+57.47K
+5.14%
Mar 31, 2025
The Vanguard Group, Inc.
1.10M
4.11%
+37.26K
+3.50%
Mar 31, 2025
Brynjelsen (Sean E)
864.94K
3.23%
-210.00K
-19.54%
Jun 05, 2025
Cannell Capital, LLC
691.37K
2.58%
+310.04K
+81.31%
Mar 31, 2025
Westside Investment Management, LLC
493.65K
1.84%
-81.57K
-14.18%
Mar 31, 2025
Susquehanna International Group, LLP
448.80K
1.67%
+256.48K
+133.36%
Mar 31, 2025
Acadian Asset Management LLC
402.43K
1.5%
+153.92K
+61.94%
Mar 31, 2025
Millennium Management LLC
355.93K
1.33%
+217.04K
+156.27%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
iShares Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
佔比0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.04%
iShares Russell 2000 Growth ETF
佔比0.02%
iShares Russell 2000 ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
Dimensional US Core Equity 1 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
